Ownership Submission
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
QUINN MICHAEL A
   2. Issuer Name and Ticker or Trading Symbol
RESMED INC [RMD] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last)
(First)
(Middle)
RESMED INC., 9001 SPECTRUM CENTER BLVD.		 3. Date of Earliest Transaction (Month/Day/Year)
08/28/2013
(Street)

SAN DIEGO, CA 92123		 4. If Amendment, Date Original Filed(Month/Day/Year)
 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)		 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		 6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)		 7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
ResMed Common Stock 08/28/2013   M   48,000 A $ 16.498 335,000 D  
ResMed Common Stock 08/28/2013   S   48,000 D $ 48.339 (2) 287,000 D  
ResMed Chess Depositary Instruments               880,000 (3) D  
ResMed Chess Depositary Instruments               306,000 (4) I Kaylara ATF Straflo Pension Fund
ResMed Chess Depositary Instruments               90,000 (5) I Spouse

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)		 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)		 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)		 6. Date Exercisable and Expiration Date
(Month/Day/Year)		 7. Title and Amount of Underlying Securities
(Instr. 3 and 4)		 8. Price of Derivative Security
(Instr. 5)		 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)		 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)		 11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
ResMed Common Stock Options $ 16.498 08/28/2013   M     48,000 07/01/2006(1) 07/01/2015 ResMed Common Stock 48,000 $ 0 0 D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
QUINN MICHAEL A
RESMED INC.
9001 SPECTRUM CENTER BLVD.
SAN DIEGO, CA 92123		   X      

Signatures

 Michael A. Quinn   08/29/2013
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Represents date options first became exercisable. Options vest 1/3 each year on the anniversary of the grant.
(2) This transaction was executed in multiple trades at prices ranging from $48.25 to $48.48. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the ransacction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.
(3) These shares are held as CDIs on the Australian Securities Exchange which represents 31,000 NYSE shares. 1 NYSE share is equal to 10 CDIs.
(4) These shares are held as CDIs on the Australian Securities Exchange which represents 30,600 NYSE shares. 1 NYSE share is equal to 10 CDIs.
(5) These shares are held as CDIs on the Australian Securities Exchange which represents 9,000 NYSE shares. 1 NYSE share is equal to 10 CDIs.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.